Evidence map›Paper›PMID 37207087›Full record

ArticleClinical case reports2023

Hairy cell leukemia with isolated bone lesions.

Laura Cailly, Cécile Gruchet, Elsa Maitre, Stephanie Guidez, Vincent Delwail, Thomas Systchenko, Niels Moya, Florence Sabirou, Anthony Levy, Arthur Bobin and 13 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Clinical case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Extramedullary Paravertebral Mass: An Unusual Presentation of Hairy Cell Leukaemia.European journal of case reports in internal medicine · 2024
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 4 institutions in 1 country.

Laura CaillyDepartment of Hematology and Cellular Therapy, and INSERM CIC1402 CHU La Miletrie, University Hospital Poitiers France.ORCID https://orcid.org/0000-0001-6169-194X
Cécile GruchetDepartment of Hematology and Cellular Therapy, and INSERM CIC1402 CHU La Miletrie, University Hospital Poitiers France.
Elsa MaitreDepartment of Hematology, CHU Cote de Nacre University Hospital Caen France.
Stephanie GuidezDepartment of Hematology and Cellular Therapy, and INSERM CIC1402 CHU La Miletrie, University Hospital Poitiers France.
Vincent DelwailDepartment of Hematology and Cellular Therapy, and INSERM CIC1402 CHU La Miletrie, University Hospital Poitiers France.
Thomas SystchenkoDepartment of Hematology and Cellular Therapy, and INSERM CIC1402 CHU La Miletrie, University Hospital Poitiers France.
Niels MoyaDepartment of Hematology and Cellular Therapy, and INSERM CIC1402 CHU La Miletrie, University Hospital Poitiers France.
Florence SabirouDepartment of Hematology and Cellular Therapy, and INSERM CIC1402 CHU La Miletrie, University Hospital Poitiers France.
Anthony LevyDepartment of Hematology and Cellular Therapy, and INSERM CIC1402 CHU La Miletrie, University Hospital Poitiers France.
Arthur BobinDepartment of Hematology and Cellular Therapy, and INSERM CIC1402 CHU La Miletrie, University Hospital Poitiers France.
Hélène GardeneyDepartment of Hematology and Cellular Therapy, and INSERM CIC1402 CHU La Miletrie, University Hospital Poitiers France.
Laly NsialaDepartment of Hematology and Cellular Therapy, and INSERM CIC1402 CHU La Miletrie, University Hospital Poitiers France.
Mathilde VonfeldDepartment of Hematology and Cellular Therapy, and INSERM CIC1402 CHU La Miletrie, University Hospital Poitiers France.
Aurélia ChaconDepartment of Hematology and Cellular Therapy, and INSERM CIC1402 CHU La Miletrie, University Hospital Poitiers France.
Aurélien PichonDepartment of Hematology and Cellular Therapy, and INSERM CIC1402 CHU La Miletrie, University Hospital Poitiers France.
Sabrina BouyerDepartment of Biology, CHU La Miletrie University Hospital Poitiers France.
Caroline BasléDepartment of Biology, CHU La Miletrie University Hospital Poitiers France.
Elodie DindinnaudDepartment of Biology, CHU La Miletrie University Hospital Poitiers France.
Jean-Claude ChomelDepartment of Biology, CHU La Miletrie University Hospital Poitiers France.
Anna RaimbaultDepartment of Biology, CHU La Miletrie University Hospital Poitiers France.
Florence Borde-MougenotDepartment of Oncology, CH Saintes Saintes France.
Xavier TroussardDepartment of Hematology, CHU Cote de Nacre University Hospital Caen France.ORCID https://orcid.org/0000-0001-6863-9992
Cécile TomowiakDepartment of Hematology and Cellular Therapy, and INSERM CIC1402 CHU La Miletrie, University Hospital Poitiers France.ORCID https://orcid.org/0000-0003-4093-6463
Inserm · FRCentre Hospitalier Universitaire de Poitiers · FRCentre Hospitalier Universitaire de Caen Normandie · FRYves Rocher (France) · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Key Clinical Message: Abstract: Bone lesions are rarely reported in Hairy Cell Leukemia (HCL). We report two BRAF

Indexed as

18F‐FDG PET/CTbone lesionscladribinehairy cell leukemiaHCLPNArituximab

Identifiers

PMID37207087
PMCPMC10188895
OpenAlexW4376959725

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.